PREFER Development of a bio-product for the treatment of difficult wounds

The project aims at developing an innovative therapeutic approach for the therapy of critical wounds, based on the expansion of autologous human endothelial cells in a bioreactor. In particular, the project wishes to demonstrate that these cells, in combination with various scaffolds, promote the re-vascularization and healing of skin wounds in a pre-clinical model of peripheral ischemia. 

Duration: 2018-2020

Donor/funding programme:

POR FESR FVG 2014-2020

Partner:

Serena Zacchigna Cardiovascular Biology, ICGEB, Trieste, Italy

VivaBiocell

University of Trieste, Italy